The Taiwanese health authorities have suspended the administering of second doses of the Pfizer-BioNTech Covid vaccine for children aged between 12 and 17, citing concerns about an increased risk of heart inflammation.
A panel of experts made the decision to cease giving the jab to teens on Wednesday, pending further review, according to the country’s Central Epidemic Command Center (CECC) head Chen Shih-chung.
The health authority opted to call a halt to the second jab due to concerns about an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart’s outer lining).
The Ministry of Health and Welfare’s Advisory Committee for Immunization Practices said it was suspending giving second doses of the inoculation to 12- to 17-year-olds for a two-week period.
During that time, experts from the country’s Centers for Disease Control will examine the 16 reported myocarditis cases among Taiwanese teens who received the ...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
